Praveen Kumar Pasala
Overview
Explore the profile of Praveen Kumar Pasala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mallela V, Rudrapal M, Prasanth D, Pasala P, Bendale A, Bhattacharya S, et al.
Front Chem
. 2024 Dec;
12:1505272.
PMID: 39734578
Lotus seeds, also known as Nelumbinis semen, has been utilized for over 7,000 years as vegetable, functional food and medicine. In this study, we primarily investigated the anticancer effects of...
2.
Bhargav E, Mohammed N, Singh U, Ramalingam P, Challa R, Vallamkonda B, et al.
Heliyon
. 2024 Sep;
10(17):e37430.
PMID: 39296160
This study aimed to enhance the efficacy of quercetin (QT) by formulating it into a liposomal drug delivery system utilizing the concept of central composite design. The drug:lipid ratio, cholesterol...
3.
Tallapalli P, Reddy Y, Yaraguppi D, Matangi S, Challa R, Vallamkonda B, et al.
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204198
Objective: This study aimed to compare the effects of β-sitosterol nanoparticles (BETNs) and β-sitosterol (BET) on cognitive impairment, oxidative stress, and inflammation in a myocardial infarction (MI) rat model using...
4.
Pasala P, Raghupathi N, Yaraguppi D, Challa R, Vallamkonda B, Ahmad S, et al.
Heliyon
. 2024 Jul;
10(12):e33154.
PMID: 39022073
The present study examined the potential neuroprotective effects of aloe-emodin (AE) nanoparticles on the cerebral stroke-associated target protein myeloperoxidase (MPO). We investigated the binding interactions between AE and MPO through...
5.
Rudrala L, Challa R, Subramanyam S, Ayyappa Gouru S, Singh G, Mulukuri N, et al.
Drug Res (Stuttg)
. 2024 Jul;
74(7):335-346.
PMID: 38991529
Ischemic stroke remains the leading cause of death and disability, while the main mechanisms of dominant neurological damage in stroke contain oxidative stress and inflammation. Docking studies revealed a binding...
6.
Pasala P, Dsnbk P, Rudrapal M, Challa R, Ahmad S, Vallamkonda B, et al.
Nat Prod Res
. 2024 Apr;
:1-10.
PMID: 38646872
Parkinson's disease (PD) is characterised by the gradual demise of dopaminergic neurons. In recent years, there has been significant interest in herbal treatments. In this study, hesperetin nanoparticles (HTN) were...
7.
K P, Prasanth D, Shadakshara M, Ahmad S, Seemaladinne R, Rudrapal M, et al.
Metabolites
. 2023 Nov;
13(11).
PMID: 37999229
One of the primary therapeutic approaches for managing Alzheimer's disease (AD) involves the modulation of Acetylcholine esterase (AChE) activity to elevate acetylcholine (ACh) levels inside the brain. The current study...
8.
Kumar R, Prasanth D, Midthuri P, Ahmad S, Badarinath A, Karumanchi S, et al.
Plants (Basel)
. 2023 Nov;
12(21).
PMID: 37960078
(Roxb.) Bosser, a member of the Rubiaceae family, is a botanical species with recognized therapeutic properties. It is commonly used in traditional medicine to treat cardiac ailments and other disorders....
9.
Lakshmi Y, Prasanth D, Sunil Kumar K, Ahmad S, Ramanjaneyulu S, Rahul N, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893129
The prevalence of Parkinson's disease places a significant burden on society; therefore, there is an urgent need to develop more effective drugs. However, the development of these drugs is both...
10.
Alluri R, Kilari E, Pasala P, Kopalli S, Koppula S
Life (Basel)
. 2023 Aug;
13(8).
PMID: 37629545
Alzheimer's disease (AD) is an age-related neuropsychiatric disorder and a common cause of progressive dementia. Diltiazem (DTZ), the non-dihydropyridine benzothiazepine class of calcium channel blocker (CCB), used clinically in angina...